[HTML][HTML] HPMA copolymer-based nanomedicines in controlled drug delivery

P Chytil, L Kostka, T Etrych - Journal of Personalized Medicine, 2021 - mdpi.com
… containing either dendron or dendrimer core, in aqueous buffers and plasma in vitro and
in vivo using PET imaging. An excellent clearance from the body was shown in vivo for the …

HPMA copolymer–drug conjugates with controlled tumor‐specific drug release

P Chytil, E Koziolová, T Etrych… - Macromolecular …, 2018 - Wiley Online Library
… pyrrolino-doxorubicin110 and THP111 were bound to HPMA … lines in vitro and enhanced
antitumor effects in vivo. Attachment of … of HPMA copolymers with pH-controlled Dox release by …

[HTML][HTML] Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor …

AK Noack, H Lucas, P Chytil, T Etrych, K Mäder… - International Journal of …, 2020 - mdpi.com
… In this study, we compared in vitro and in vivo accumulation … In this system, the cytotoxic
drug is covalently bound to the … structured HPMA-copolymer drug conjugate with doxorubicin (…

Bloodstream stability predetermines the antitumor efficacy of micellar polymer–doxorubicin drug conjugates with pH-triggered drug release

P Chytil, M Šírová, J Kudláčová… - Molecular …, 2018 - ACS Publications
… by a hydrazone bond enabling pH-controlled drug release. While the polymer–… HPMA
copolymer–Dox conjugates forming micelles in aqueous solution on their biological effects in vivo. …

The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia

B Tomalova, M Sirova, P Rossmann, R Pola… - … of Controlled Release, 2016 - Elsevier
doxorubicin (DOX) bound via pH-sensitive hydrazone bond. We determined the in vitro
and in vivo … investigated the in vitro and in vivo biological activity of two HPMA copolymer-based …

Pronounced cellular uptake of pirarubicin versus that of other anthracyclines: comparison of HPMA copolymer conjugates of pirarubicin and doxorubicin

H Nakamura, E Koziolová, P Chytil… - Molecular …, 2016 - ACS Publications
… and a cytotoxicity that was … copolymer carrier, with regard to their uptake by tumor cells,
body distribution, accumulation in tumors, cytotoxicity, and antitumor activity in vitro and in vivo. …

The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and …

M Šírová, J Strohalm, P Chytil, O Lidický… - … of Controlled Release, 2017 - Elsevier
HPMA-based conjugates of cytotoxic drugs have shown the in vivo ability to deliver the
cytostatic/cytotoxic … Ample evidence shows that HPMA copolymer conjugates carrying Dox or Dtx …

… nanomedicines based on micelle-forming amphiphilic or water-soluble polymer-doxorubicin conjugates: Comparative study of in vitro and in vivo properties related to …

A Braunová, P Chytil, R Laga, M Šírová… - … of controlled release, 2020 - Elsevier
… groups alongside the hydrophilic HPMA copolymer. These groups … Dox release from the
whole micellar system, resulting in both reduced in vitro cytotoxicity and therapeutic effect in vivo

PEGylated N-(2 hydroxypropyl) methacrylamide-doxorubicin conjugate as pH-responsive polymeric nanoparticles for cancer therapy

Y Bobde, S Biswas, B Ghosh - Reactive and Functional Polymers, 2020 - Elsevier
… backbone biodegradable multiblock HPMA copolymer, paclitaxel … was conjugated to HPMA
via hydrazone bond (HPMA-NH-… The in-vitro cytotoxicity of P6-NPs was evaluated using MTT …

Current trends in the development of HPMA-based block copolymeric nanoparticles for their application in drug delivery

Y Bobde, S Biswas, B Ghosh - European Polymer Journal, 2020 - Elsevier
… -lactate) for multimodal in vivo and ex vivo optical imaging [55… sequence for pH-controlled
drug release and enzymatic … In our recent study, PEGylated HPMA-doxorubicin conjugate …